Despite the rising popularity of the minimally invasive laparoscopic option, open nephron-sparing surgery is still seen by many experts as the 'gold standard' for open surgery for kidney tumors and should remain the first choice for many patients. This challenges the idea that less-invasive therapies are always more desirable than open surgery. Whi

Accompanying DVD-ROM, in pocket at front of v. 1, contains ... "video clips referenced in the text."--DVD-ROM label.

​Surgical Techniques for Kidney Cancer provides a comprehensive review and detailed description of surgical techniques for kidney and adrenal cancer. Through a step by step approach various surgical techniques are covered including radical nephrectomy, partial nephrectomy, and thermal ablation for renal cortical tumors. Each step by step approach is followed by the latest data on outcomes. Furthermore, limitations as well as tips and tricks are detailed in addition to management of common complications. Kidney Surgery for Urologists will be a valuable resource for Urologists, Urological Surgeons, Fellows in Urologic Oncology and Minimally Invasive/Robotic Surgery as well as upper level residents training in Urology.​

This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist. Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.

The Guest Editors have secured the top urologists to provide current clinical reviews on the latest advances in the management of small renal masses. Articles are devoted to the following topics: hereditary yndromes; trends in renal surgery; humor anatomic complexity; risk assessment; renal biopsy; active surveillance; ablation; surgical techniques; renal ischemia; lymph node dissection; complications; neoadjuvant targeted therapy for renal surgery; salvage surgery; and post-operative surveillance. Readers will come away with a succinct overview of the most clinically relevant articles and be able to immediately implement the clinical information in their practice.

Kidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, Onco-Nephrology provides authoritative, definitive coverage of the mechanism and management of these two life-threatening diseases. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed. Addresses acute and chronic kidney diseases that develop from a variety of cancers. This includes direct kidney injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the malignancy. Discusses key issues regarding kidney disease in patients with cancer, including conventional chemotherapeutic regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney transplantation, which has been shown to carry an increased risk of cancer. Contains dedicated chapters for each class of the conventional chemotherapeutic agents, targeted cancer agents, and cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and treatment. Includes special chapters devoted to the individual classes of chemotherapies that relate to kidney disease for quick reference. Discusses increasingly complex problems due to more numerous and specialized anti-cancer drugs, as well as increased survival rates for both cancer and renal failure requiring long-term patient care. Covers anti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies – treatments that are being recognized for adverse kidney effects. Utilizes a clear, logical format based on the ASN Core Curriculum for Onco-Nephrology, making this reference an excellent tool for board review, as well as a practical resource in daily practice.